Skip to content
2000
image of Niosomes: A Revolutionary Approach for Skin Cancer Treatment

Abstract

Skin cancer is one of the most common types of cancer globally, with melanoma and non-melanoma being the two primary forms. Melanoma tends to be less frequent but more dangerous, while non-melanoma types, including squamous and basal cell carcinoma, are more prevalent. Caucasian populations are at a higher risk of developing skin cancer due to their skin's susceptibility to ultraviolet (UV) radiation. According to recent data, skin cancer ranks as the seventeenth most common cancer worldwide. An emerging approach to treating skin conditions, including skin cancer, is using niosomes, an advanced drug delivery system. Niosomes are vesicles made from non-ionic surfactants, stabilized by cholesterol, that encapsulate drugs. They have gained prominence because they address several issues related to traditional topical treatments, such as poor solubility, instability, low bioavailability, and rapid drug breakdown. This review article focuses on the use of niosomes in dermatology, particularly for drug delivery through the skin. Niosomes offer several distinct advantages, making them an ideal choice for topical drug delivery. Their unique structure allows them to transport both water-soluble and fat-soluble drugs effectively. Additionally, they enhance drug permeation through the skin, improve drug stability, and allow for extended drug release. These properties make niosomes a valuable tool in clinical settings, providing potential benefits for a range of skin-related therapies. With their growing popularity, niosomes are shaping the future of innovative and more efficient topical drug delivery methods.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cnanom/10.2174/0124681873335092250115022230
2025-01-28
2025-09-19

  • From This Site

    /content/journals/cnanom/10.2174/0124681873335092250115022230
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Shinu P. Nair A.B. Kumari B. Jacob S. Kumar M. Tiwari A. Tiwari V. Venugopala K.N. Attimarad M. Nagaraja S. Recent advances and appropriate use of niosomes for the treatment of skin cancer. Indian J. Pharmaceut. Educ. Res. 2022 56 4 10.5530/ijper.56.4.170
    [Google Scholar]
  2. Bharath A. Turner R. Impact of climate change on skin cancer. J. R. Soc. Med. 2009 102 6 215 218 10.1258/jrsm.2009.080261 19531614
    [Google Scholar]
  3. Corona R. Dogliotti E. D’Errico M. Sera F. Iavarone I. Baliva G. Chinni L.M. Gobello T. Mazzanti C. Puddu P. Pasquini P. Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life. Arch. Dermatol. 2001 137 9 1162 1168 10.1001/archderm.137.9.1162 11559211
    [Google Scholar]
  4. Tilli C.M.L.J. Van Steensel M.A.M. Krekels G.A.M. Neumann H.A.M. Ramaekers F.C.S. Molecular aetiology and pathogenesis of basal cell carcinoma. Br. J. Dermatol. 2005 152 6 1108 1124 10.1111/j.1365‑2133.2005.06587.x 15948971
    [Google Scholar]
  5. Ziegler A. Jonason A.S. Leffellt D.J. Simon J.A. Sharma H.W. Kimmelman J. Remington L. Jacks T. Brash D.E. Sunburn and p53 in the onset of skin cancer. Nature 1994 372 6508 773 776 10.1038/372773a0 7997263
    [Google Scholar]
  6. Staples M.P. Elwood M. Burton R.C. Williams J.L. Marks R. Giles G.G. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med. J. Aust. 2006 184 1 6 10 10.5694/j.1326‑5377.2006.tb00086.x 16398622
    [Google Scholar]
  7. Welch H.G. Woloshin S. Schwartz L.M. Skin biopsy rates and incidence of melanoma: population based ecological study. BMJ 2005 331 7515 481 10.1136/bmj.38516.649537.E0 16081427
    [Google Scholar]
  8. Lee J.A.H. Scotto J. Melanoma: linked temporal and latitude changes in the United States. Cancer Causes Control 1993 4 5 413 418 10.1007/BF00050859 8218872
    [Google Scholar]
  9. Autier P. Perspectives in melanoma prevention: the case of sunbeds. Eur. J. Cancer 2004 40 16 2367 2376 10.1016/j.ejca.2004.07.018 15519507
    [Google Scholar]
  10. Whitmore S.E. Morison W.L. Melanoma after PUVA therapy for psoriasis. N. Engl. J. Med. 1997 337 7 502 503 10.1056/NEJM199708143370716 9254340
    [Google Scholar]
  11. World Health Organization. Search result. 2024 Available from:https://www.who.int/home/search-results?indexCatalogue=genericsearchindex1&searchQuery=skin%20cancer&wordsMode=AnyWord(accessed on 12-11-2024).
  12. Saraiya M. Glanz K. Briss P.A. Nichols P. White C. Das D. Smith S.J. Tannor B. Hutchinson A.B. Wilson K.M. Gandhi N. Lee N.C. Rimer B. Coates R.C. Kerner J.F. Hiatt R.A. Buffler P. Rochester P. Interventions to prevent skin cancer by reducing exposure to ultraviolet radiation. Am. J. Prev. Med. 2004 27 5 422 466 10.1016/j.amepre.2004.08.009 15556744
    [Google Scholar]
  13. Collins S.A. Thompson S.H. What are we feeding our inmates? J. Correct. Health Care 2012 18 3 210 218 10.1177/1078345812444875 22553283
    [Google Scholar]
  14. Aslan Ö. The United States and Military Coups in Turkey and Pakistan Springer 2018 10.1007/978‑3‑319‑66011‑0_5
    [Google Scholar]
  15. Dilsizian S.E. Siegel E.L. Artificial intelligence in medicine and cardiac imaging: harnessing big data and advanced computing to provide personalized medical diagnosis and treatment. Curr. Cardiol. Rep. 2014 16 1 441 10.1007/s11886‑013‑0441‑8 24338557
    [Google Scholar]
  16. Gadeliya Goodson A. Grossman D. Strategies for early melanoma detection: Approaches to the patient with nevi. J. Am. Acad. Dermatol. 2009 60 5 719 735 10.1016/j.jaad.2008.10.065 19389517
    [Google Scholar]
  17. Seyfried T.N. Huysentruyt L.C. On the origin of cancer metastasis. Crit. Rev. Oncog. 2013 18 1-2 43 73 10.1615/CritRevOncog.v18.i1‑2.40
    [Google Scholar]
  18. Le Clair M.Z. Cockburn M.G. Tanning bed use and melanoma: Establishing risk and improving prevention interventions. Prev. Med. Rep. 2016 3 139 144 10.1016/j.pmedr.2015.11.016 27419006
    [Google Scholar]
  19. Chandu V.P. Arunachalam A. Jeganath S. Yamini K. Tharangini K. Chaitanya G. Niosomes: a novel drug delivery system. Int. J. Novel Trends Pharm. Sci. 2012 2 1 25 31 https://www.scienztech.org/index.php/ijntps/article/view/58
    [Google Scholar]
  20. Khandare J.N. Madhavi G. Tamhankar B.M. Niosomes-novel drug delivery system. Eastern Pharmacist. 1994 37 61 10.5281/zenodo.10850135
    [Google Scholar]
  21. Baillie A.J. Florence A.T. Hume L.R. Muirhead G.T. Rogerson A. The preparation and properties of niosomes—non-ionic surfactant vesicles. J. Pharm. Pharmacol. 1985 37 12 863 868 10.1111/j.2042‑7158.1985.tb04990.x 2868092
    [Google Scholar]
  22. Talegaonkar S. Mishra P.R. Khar R.K. Biju S.S. Vesicular systems: An overview. Indian J. Pharm. Sci. 2006 68 2 141 10.4103/0250‑474X.25707
    [Google Scholar]
  23. Uchegbu I.F. Vyas S.P. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int. J. Pharm. 1998 172 1-2 33 70 10.1016/S0378‑5173(98)00169‑0
    [Google Scholar]
  24. Malhotra M. Jain N.K. Niosomes as drug carriers. Indian J. Pharm. Sci. 1994 58 2 41 46
    [Google Scholar]
  25. Alsarra I.A. Bosela A.A. Ahmed S.M. Mahrous G.M. Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur. J. Pharm. Biopharm. 2005 59 3 485 490 10.1016/j.ejpb.2004.09.006 15760729
    [Google Scholar]
  26. Sharma R. Dua J.S. Prasad D.N. Hira S. Monika Advancement in novel drug delivery system: niosomes. J. Drug Deliv. Ther. 2019 9 3-s 995 1001 10.22270/jddt.v9i3‑s.2931
    [Google Scholar]
  27. Makeshwar K.B. Wasankar S.R. Niosome: A novel drug delivery system. Asian J. Pharmaceut. Res. 2013 3 1 5691 10.5958/2231–5691
    [Google Scholar]
  28. Katare R. Gupta P.N. Mahor S. Rawat A. Khatri K. Katare Y. Panda A.K. Vyas S.P. Development of polysaccharide-capped niosomes for oral immunization of tetanus toxoid. J. Drug Deliv. Sci. Technol. 2006 16 3 167 172 10.1016/S1773‑2247(06)50031‑0
    [Google Scholar]
  29. Arul J. Shanmuganathan S. An overview on niosome as carrier in dermal drug delivery. J. Pharm. Sci. Res. 2015 7 11 923 927
    [Google Scholar]
  30. Moghassemi S. Hadjizadeh A. Nano-niosomes as nanoscale drug delivery systems: An illustrated review. J. Control. Release 2014 185 22 36 10.1016/j.jconrel.2014.04.015 24747765
    [Google Scholar]
  31. Sankhyan A. Pawar P. Recent Trends in Niosome as Vesicular DrugDelivery System. J. Appl. Pharm. Sci. 2012 ••• 20 32 10.7324/JAPS.2012.2625
    [Google Scholar]
  32. Rogerson A. Cummings J. Willmott N. Florence A.T. The distribution of doxorubicin in mice following administration in niosomes. J. Pharm. Pharmacol. 1988 40 5 337 342 10.1111/j.2042‑7158.1988.tb05263.x 2899629
    [Google Scholar]
  33. Mayer L.D. Bally M.B. Hope M.J. Cullis P.R. Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. Biochim. Biophys. Acta Biomembr. 1985 816 2 294 302 10.1016/0005‑2736(85)90497‑3 3839135
    [Google Scholar]
  34. Singh G. Dwivedi H. Saraf S.K. Saraf S.A. Niosomal delivery of isoniazid-development and characterization. Trop. J. Pharm. Res. 2011 10 2 10.4314/tjpr.v10i2.66564
    [Google Scholar]
  35. Lohumi A. A novel drug delivery system: niosomes review. J. Drug Deliv. Ther. 2012 2 5 10.22270/jddt.v2i5.274
    [Google Scholar]
  36. Madhav N.V. Saini A. Niosomes: a novel drug delivery system. Int. J. Res. Pharm. Chem. 2011 1 3 498 511
    [Google Scholar]
  37. Naik N. Chouksey S. Niosome: A promising pharmaceutical drug delivery. Int. J. Pharmaceut. Drug Anal. 2014 2 5
    [Google Scholar]
  38. Shakya V. Bansal B.K. Niosomes: A novel trend in drug delivery. Int. J. Res. Develop. Pharm. Life Sci. 2014 3 4 1036 1041
    [Google Scholar]
  39. Mandal K.M. Niosome: A future of targeted drug delivery systems. J. Adv. Pharmaceut. Technol. Res. 2010 1 4 10.4103/0110‑5558.76435
    [Google Scholar]
  40. Keshav J. Niosomes as apotential carrier system: a review. Int. J. Pharm. Chem. Biol. Sci. 2015 5 4
    [Google Scholar]
  41. Sarker A. Shimu I.J. Alam S.A. Niosome: as dermal drug delivery tool. IOSR J. Pharm. Biol. Sci. 2015 10 2 73 79
    [Google Scholar]
  42. Nasir A. Harikumar S.L. Amanpreet K. Niosomes: An excellent tool for drug delivery. Int. J. Res. Pharm. Chem. 2012 2 2 479 487
    [Google Scholar]
  43. Rane B.R. Patil R.S. Jain A.S. Formulation development and evaluation of nanogel loaded with montelukast sodium niosomes. Int. J. Pharm. Sci. Res. 2021 12 8 4208 4221 10.13040/IJPSR.0975‑8232.12(8).4208‑21
    [Google Scholar]
  44. Tangri P. Khurana S. Niosomes: Formulation and evaluation. Int. J. 2011 2229 7499
    [Google Scholar]
  45. Kumari R. Verma K. Verma A. Yadav G.K. Maurya S.D. Proniosomes: A key to improved drug delivery. J. Drug Deliv. Ther. 2014 0 0 56 65 10.22270/jddt.v0i0.875
    [Google Scholar]
  46. Kaur D. Kumar S. Niosomes: Present scenario and future aspects. J. Drug Deliv. Ther. 2018 8 5 35 43 10.22270/jddt.v8i5.1886
    [Google Scholar]
  47. Suma U.S. Parthiban S. Senthil Kumar G.P. Tamiz Mani T. Novelty of niosomal gel in tdds application. Asian J. Res. Biol. Pharma. Sci. 2015 3 2 41 48
    [Google Scholar]
  48. Srivastava N.S. Thakur S. Kaur J. Niosomes: a novel approach for topical delivery of drugs. 2016 Available from:https://www.semanticscholar.org/paper/NIOSOMES%3A-A-NOVEL-APPROACH-FOR-TOPICAL-DELIVERY-OF/92968d790a887e7b21c4fac99b8ef22c5531910f(accessed on 12-11-2024).
  49. Alkilani A. McCrudden M.T. Donnelly R. Transdermal drug delivery: Innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics 2015 7 4 438 470 10.3390/pharmaceutics7040438 26506371
    [Google Scholar]
  50. Dabkowska A.P. Barlow D.J. Campbell R.A. Hughes A.V. Quinn P.J. Lawrence M.J. Effect of helper lipids on the interaction of DNA with cationic lipid monolayers studied by specular neutron reflection. Biomacromolecules 2012 13 8 2391 2401 10.1021/bm300639n 22724519
    [Google Scholar]
  51. Mochizuki S. Kanegae N. Nishina K. Kamikawa Y. Koiwai K. Masunaga H. Sakurai K. The role of the helper lipid dioleoylphosphatidylethanolamine (DOPE) for DNA transfection cooperating with a cationic lipid bearing ethylenediamine. Biochim. Biophys. Acta Biomembr. 2013 1828 2 412 418 10.1016/j.bbamem.2012.10.017 23092705
    [Google Scholar]
  52. Musielak E. Feliczak-Guzik A. Nowak I. Synthesis and potential applications of lipid nanoparticles in medicine. Materials (Basel) 2022 15 2 682 10.3390/ma15020682 35057398
    [Google Scholar]
  53. Jacob S. Nair A.B. Shah J. Sreeharsha N. Gupta S. Shinu P. Emerging role of hydrogels in drug delivery systems, tissue engineering and wound management. Pharmaceutics 2021 13 3 357 10.3390/pharmaceutics13030357 33800402
    [Google Scholar]
  54. Souza J.G. Gelfuso G.M. Simão P.S. Borges A.C. Lopez R.F.V. Iontophoretic transport of zinc phthalocyanine tetrasulfonic acid as a tool to improve drug topical delivery. Anticancer Drugs 2011 22 8 783 793 10.1097/CAD.0b013e3283468979 21487287
    [Google Scholar]
  55. Taveira S.F. Nomizo A. Lopez R.F.V. Effect of the iontophoresis of a chitosan gel on doxorubicin skin penetration and cytotoxicity. J. Control. Release 2009 134 1 35 40 10.1016/j.jconrel.2008.11.002 19047006
    [Google Scholar]
  56. Nair A. Vyas H. Shah J. Kumar A. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin. Drug Deliv. 2011 18 1 19 25 10.3109/10717544.2010.509361 20726811
    [Google Scholar]
  57. Cosco D. Paolino D. Muzzalupo R. Celia C. Citraro R. Caponio D. Picci N. Fresta M. Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracil. Biomed. Microdevices 2009 11 5 1115 1125 10.1007/s10544‑009‑9328‑2 19507033
    [Google Scholar]
  58. Rajera R. Nagpal K. Singh S.K. Mishra D.N. Niosomes: A controlled and novel drug delivery system. Biol. Pharm. Bull. 2011 34 7 945 953 10.1248/bpb.34.945 21719996
    [Google Scholar]
  59. Chinembiri T.N. Gerber M. Du Plessis L.H. Du Preez J.L. Hamman J.H. Du Plessi Alcantar N. Williams E.C. Toomey R. Topical delivery of Withania somnifera crude extracts in niosomes and solid lipid nanoparticles. Pharmacogn. Mag. 2017 13 S3 663 671
    [Google Scholar]
  60. Candido T.Z. de Paiva R.E.F. Figueiredo M.C. de Oliveira Coser L. Frajácomo S.C.L. Abbehausen C. Cardinalli I.A. Lustri W.R. Carvalho J.E. Ruiz A.L.T.G. Corbi P.P. Lima C.S.P. Silver nimesulide complex in bacterial cellulose membranes as an innovative therapeutic method for topical treatment of skin squamous cell carcinoma. Pharmaceutics 2022 14 2 462 10.3390/pharmaceutics14020462 35214194
    [Google Scholar]
  61. Bhattacharya S. Prajapati B.G. Formulation, design and development of niosome based topical gel for skin cancer. Med Clin Res. 2017 2 3 1 23
    [Google Scholar]
  62. Shah H.S. Gotecha A. Jetha D. Rajput A. Bariya A. Panchal S. Butani S. Gamma oryzanol niosomal gel for skin cancer: formulation and optimization using quality by design (QbD) approach. AAPS Open 2021 7 1 9 10.1186/s41120‑021‑00041‑2
    [Google Scholar]
  63. Chermahini S.H. Najafi R.B. Niosome encapsulated fluorouracil as drug delivery system to basal-cell skin Cancer. J. Nanosci. Nanomed. 2019 3 1 4
    [Google Scholar]
  64. Al-mahallawi A.M. Fares A.R. Abd-Elsalam W.H. Enhanced permeation of methotrexate via loading into ultra-permeable niosomal vesicles: fabrication, statistical optimization, ex-vivo studies, and in vivo skin deposition and tolerability. AAPS PharmSciTech 2019 20 5 171 10.1208/s12249‑019‑1380‑5 31004239
    [Google Scholar]
  65. Rajkumar J. Venkata Radha G. Topical drug delivery of 5-fluorouracil proniosomal gel for the treatment of skin cancer: in vitro and in vivo evaluation. Pharmaceut. Sci. Asia 2021 48 2 147 163 10.29090/psa.2021.02.20.002
    [Google Scholar]
  66. Fahmy S.A. Ramzy A. Sawy A.M. Nabil M. Gad M.Z. El-Shazly M. Aboul-Soud M.A.M. Azzazy H.M.E.S. Ozonated olive oil: Enhanced cutaneous delivery via niosomal nanovesicles for melanoma treatment. Antioxidants 2022 11 7 1318 10.3390/antiox11071318 35883809
    [Google Scholar]
  67. Oommen E. Shenoy B.D. Udupa N. Kamath R. Devi P.U. Antitumour efficacy of cyclodextrin-complexed and niosome- encapsulated plumbagin in mice bearing melanoma B16F1. Pharm. Pharmacol. Commun. 1999 5 4 281 285 10.1211/146080899128734857
    [Google Scholar]
  68. Attia H.H. Shaker D.S. ElMeshad A. El-Kayal M. Optimization and in-vitro assessment of the effectiveness of carvedilol-loaded proniosomal gels as a promising therapeutic approach for the topical treatment of skin cancer. J. Drug Deliv. Sci. Technol. 2023 86 104665 10.1016/j.jddst.2023.104665
    [Google Scholar]
  69. Gupta D.K. Aqil M. Ahad A. Imam S.S. Waheed A. Qadir A. Iqubal M.K. Sultana Y. Tailoring of berberine loaded transniosomes for the management of skin cancer in mice. J. Drug Deliv. Sci. Technol. 2020 60 102051 10.1016/j.jddst.2020.102051
    [Google Scholar]
  70. Alcantar N. Williams E.C. Toomey R. Niosome-hydrogel drug delivery system. Patent US 12/622693, 2010
  71. Smith G. Shenoy D.B. Lee R.W. Adjuvant and vaccine compositions. Patent US 12/280099, 2010.
  72. Alcantar N. Dearborn K. VanAuker M. Toomey R. Hood E. Niosome-hydrogel drug delivery. Patent US 11/737,271, 2008.
  73. Awasthi R. Kumar S.T. Kulkarni G. Frontier lipid-based carrier systems for drug targeting: A laconic review on niosomes. Pharm. Nanotechnol. 2014 2 3 116 128 10.2174/2211738503666150107234904
    [Google Scholar]
  74. Hood E. Gonzalez M. Plaas A. Strom J. VanAuker M. Immuno-targeting of nonionic surfactant vesicles to inflammation. Int. J. Pharm. 2007 339 1-2 222 230 10.1016/j.ijpharm.2006.12.048 17448616
    [Google Scholar]
  75. Yang C.C. Le Y.C. Liu C.C. Compositions and methods of enhanced transdermal delivery of steroid compounds and preparation methods. Patent US 10/828700, 2005.
/content/journals/cnanom/10.2174/0124681873335092250115022230
Loading
Niosomes: A Revolutionary Approach for Skin Cancer Treatment
Bentham Science Publishers ; https://doi.org/10.2174/0124681873335092250115022230
/content/journals/cnanom/10.2174/0124681873335092250115022230
/content/journals/cnanom/10.2174/0124681873335092250115022230
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: topical drug delivery ; melanoma ; carcinomas ; Skin cancer ; niosome

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test